Company has a long history of supplying medicines to the state, including HIV treatments and measles vaccines
The health department’s unexpected decision to purchase pneumococcal vaccines from the local subsidiary of Indian generic pharmaceutical company Cipla instead of local vaccine manufacturer Biovac will save the government R2.4bn, Cipla said on Wednesday.
Biovac entered into a partnership with pharmaceutical giant Pfizer in 2015 to help make its pneumococcal vaccine, in the expectation that it would supply the state with the shots produced at its facility in Pinelands. But in a surprise move, the health department announced last week that it had switched to Cipla for the next three-year contract, which begins in 2024. Cipla’s SA subsidiary signed an agreement with the Serum Institute of India in 2015 to import its vaccines into SA...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
State snubs SA vaccine maker Biovac with switch to importsSA’s state-backed vaccine manufacturer dealt a blow by health department as SA plans to import shots from Cipla
Read more »
How a smart kid ended up with a smart gun company to sellGuns that won’t fire for anyone else might prevent a wide range of gun-related accidents and deaths
Read more »
Must Be Nice – Insurance Company CEOs In South Africa Are Earning...Holy cow, Discovery CEO Adrian Gore better be making high-stakes decisions on a daily basis to justify his maddeningly good salary.
Read more »
Meta begins company-wide layoffs - TechCentralMeta Platforms is set to commence company-wide layoffs as it works towards founder Mark Zuckerberg’s goal of greater efficiency.
Read more »
Nigeria: Hope for Millions As Nigeria Approves Malaria VaccineSimilar to Ghana, Mrs Adeyeye said the vaccine is indicated for the prevention of malaria in children from 5 months to 36 months of age.
Read more »
Uganda: Vaccine Against Malaria in Children Gets ApprovalGhana on April 13 became the first country to approve public usage of a new experimental vaccine for children to protect them from malaria.
Read more »